Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: Pending USPTO Reexamination Certicate US "336" Patent
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Pending USPTO Reexamination Certicate US "336" Patent
posted on
Apr 16, 2010 01:41PM
If PTSC received a favorable approval from the USPTO on the Reexamination Certicate for US Patent "336" how does that change the way in which PTSC goes after the "infringer's", rather I guess, how does TPL handle the "infringer's"